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Bidirectional associations 
between rheumatoid arthritis 
and depression: a nationwide 
longitudinal study
Ming-Chi Lu1,2,*, How-Ran Guo3,4,5,*, Miao-Chiu Lin6,*, Hanoch Livneh7,*, Ning-Sheng Lai1,2 & 
Tzung-Yi Tsai3,8,9
Rheumatoid arthritis (RA) and depression may be associated with each other pathophysiologically, 
but few studies have been conducted on the interplay between these two diseases using longitudinal 
measurement. Therefore, we used the National Health Insurance Research Database of Taiwan to 
investigate the bidirectional associations between RA and depression. One cohort was included to 
analyze RA predicting the onset of depression and a second cohort for analysis of depression predicting 
RA. A sex- and age-matched control group was included for both. The incidence of depression in RA 
subjects was higher than in non-RA subjects [15.69 vs. 8.95 per 1,000 person-years (PYs)], with an 
adjusted hazard ratios (HRs) of 1.69 [95% confidence interval (CI), 1.51–1.87]. The incidence of RA was 
higher in depressed than non-depressed individuals (2.07 vs. 1.21 per 1,000 PYs), with an adjusted 
HRs of 1.65 (95% CI, 1.41–1.77). This population-based cohort study suggested strong bidirectional 
relationships between RA and depression. Healthcare providers are recommended to facilitate the 
implementation of more effective therapeutic interventions to achieve favorable prognosis, especially 
for those with new-onset or younger cases.
Although the possible mechanisms linking psychiatric disorders and rheumatoid arthritis (RA) still remain 
unclear1, some studies reported that a clear clustering of depressive symptoms among patients with RA2–5. 
Notably, those RA patients suffering from concomitant depression had nearly a 7.2% increase in medical costs 
per year ($12,225 vs. $11,404)6, and more than doubled the likelihood of mortality compared to patients with RA 
only7, suggesting that prompt provision of psychosocial support is of utmost importance.
The comorbid relationship may imply a putative causal link between RA and depression, possibly through a 
dysfunctional neuroendocrine system2,8,9. Some empirical reviews further demonstrated that intracellular signal-
ing pathways, such as PI-3K/AKT/mTOR and stress- and mitogen-activated protein kinases (SAPK/MAPK), may 
provide a connection between the two diseases10–12. However, unlike studies on the risk of depression in patients 
with RA3–5,13, empirical research examining whether there is also an elevated risk of RA in patients with depres-
sion are sparse and the results are conflicting. A community survey involving 7,076 subjects found no relationship 
between the occurrence of depression and the predisposition of rheumatologic disorders14, whereas two other 
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studies found that depression was associated with a greater-adjusted risk of arthritis onset as compared to those 
in which this condition was absent15,16.
Given the corresponding health care burden and adverse clinical manifestations of these medical conditions, 
the understanding of the bidirectional relationships between the RA and depression has become a pressing issue, 
and would be of great importance in setting prevention efforts and priorities for reducing the presence of con-
comitant depressive symptoms among RA subjects, and RA risk among patients with depression. To our knowl-
edge, to date, only one study has conducted such analyses which were based on these populations14. This study, 
however, was limited due to the cross-sectional design and self-administered questionnaire, which could be dif-
ferent from clinical diagnosis and confounded by recall bias. To address this concern, we applied claim data from 
the National Health Insurance (NHI) of Taiwan to better understand the risk of developing RA among patients 
with depression and the risk of developing depression among RA patients.
Results
First Analysis: RA and the Subsequent Risk of Depression. Table 1 shows the basic characteristics of 
the RA and non-RA cohorts. We established a cohort of 8,331 RA patients and a non-RA cohort of 15,456 sub-
jects. Age and sex distributions were similar for both cohorts with a mean age of approximately 54 years of age, 
and a majority (over 2/3) of female patients in both groups. RA cohorts were more likely to reside in a rural area 
(P < 0.01) and suffer from some common comorbidities, including hypertension, heart disease, stroke, chronic 
kidney disease, diabetes, and alcohol dependence syndrome (all P < 0.01).
In all subjects, a total of 2,033 episodes of depression occurred, which consisted of 958 among RA cohorts and 
1,075 among the non-RA cohorts during 61,075.48 and 12,100.95 PYs of follow-up, respectively. Incidence of 
depression in RA cohorts was higher than in the non-RA cohorts (15.69 vs. 8.95 per 1,000 PYs), with an adjusted 
HRs of 1.69 [95% confidence interval (CI), 1.51–1.87] as shown in Table 2. Additionally, among male and female 
cohorts with RA, the adjusted HRs of depression during the 14-year follow-up period were, respectively, 1.65 and 
1.73 for the risk of depression. The hazards were comparable between men and women (P = 0.78). On the other 
hand, regardless of gender, the age-stratified analysis revealed that age significantly interacted with RA on the risk 
of depression, in which the higher adjusted HRs were observed in both female and male RA cohorts aged≤ 40 
years (2.14; 95% CI, 1.62–2.69 and 2.76; 95% CI, 1.83–4.59, respectively). The interactions were confirmed by 
further analyses showing that the interaction term of age and RA was statistically significant in both sexes (all 
P < 0.05). Analysis stratified by the time from RA diagnosis showed that the higher incidence rates of depression 
in the RA cohorts, as compared to the non-RA cohorts, occurred within two years since RA diagnosis, with 
adjusted HRs of 1.98 (95% CI, 1.43–2.15).
Variables
Non-RA cohort RA cohort
PN = 15456(%) N = 8331(%)
Age, (years) 0.62
< = 40 2587(16.7) 1359(16.3)
41–60 7441(48.1) 4004(48.1)
60+ 5428(35.1) 2968(35.6)













Hypertension 3014(19.5) 2426(29.1) < 0.001
Stroke 606(3.9) 425(5.1) < 0.001
Diabetes 1412(9.1) 1162(13.9) < 0.001
Heart disease 1437(9.3) 1335(16.0) < 0.001
Chronic kidney disease 181(1.2) 160(1.9) < 0.001
Cancer 473(3.1) 269(3.2) 0.48
Alcohol dependence syndrome 7(0.0) 15(0.2) 0.001
Tobacco use 22(0.1) 14(0.2) 0.63
Table 1.  Demographic data and comorbidity comparison of the study subjects.
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Second Analysis: Depression and the Subsequent Risk of RA. The distributions of baseline char-
acteristics in the depression and non-depression cohorts are summarized in Table 3. Mean age of cohorts with 
depression was 48.26, similar to that of the non-depression cohorts of 48.16. We found that the depression 
cohorts were more likely to reside in less urbanized area (P < 0.01) and had comorbidities such as hypertension, 
heart disease, stroke, chronic kidney disease, diabetes, cancer, alcohol dependence syndrome, and tobacco use 
(all P < 0.01).
Variables
Non-RA cohort RA cohort HR (95% CI)
Case PYs Incidence Case PYs Incidence Crude Adjusted
All 1075 120100.95 8.95 958 61075.48 15.69 1.75 (1.60–1.91) 1.69* (1.51–1.87)
Sex
 Female 834 79153.66 10.54 749 40500.41 18.49 1.76 (1.57–1.93) 1.73ξ (1.50–1.84)
 < = 40 123 14034.12 8.76 130 6855.65 18.96 2.16 (1.67–2.73) 2.14Υ (1.62–2.69)
 41–60 427 38820.73 10.99 365 19759.52 18.47 1.68 (1.45–1.99) 1.60Υ (1.35–1.90)
 > 60 284 26298.81 10.79 254 13885.25 18.29 1.67 (1.42–1.92) 1.58Υ (1.37–1.82)
 Male 241 40947.29 5.89 209 20575.07 10.16 1.72 (1.43–2.06) 1.65ξ (1.33–1.94)
 < = 40 28 7405.85 3.78 40 3548.01 11.27 2.97 (1.81–4.77) 2.76Υ (1.83–4.59)
 41–60 90 17265.70 5.21 78 8682.50 8.98 1.72 (1.27–2.33) 1.59Υ (1.17–2.17)
 > 60 123 16275.75 7.56 91 8344.56 10.90 1.44 (1.10–1.88) 1.33Υ (1.01–1.75)
Follow–up (years) 
 ≦ 2 161 2481.50 64.88 195 1328.31 146.77 2.25 (1.71–2.44) 1.98* (1.43–2.15)
 3–5 483 8666.64 55.73 443 5423.28 81.68 1.48 (1.34–1.73) 1.47* (1.28–1.76)
 > 5 431 108952.81 3.96 320 54323.89 5.89 1.50 (1.30–1.74) 1.48* (1.25–1.69)
Table 2.  Association of depression with RA stratified by sex, age, and follow-up years. Incidence rate is per 
1,000 PYs. Υ Model adjusted for urbanization level, monthly income, and comorbidity. ξ Model adjusted for 
age, urbanization level, monthly income, and comorbidity. *Model adjusted for age, gender, urbanization level, 




PN = 88,688 (%) N = 44,727 (%)
Age, (years) 0.60
< = 40 31232(35.2) 15646(35.0)
41–60 35230(39.7) 17774(39.7)
60+ 22226(25.1) 11307(25.3)













Hypertension 12894(17.0) 11740(26.3) < 0.001
Stroke 2432(3.2) 4435(9.9) < 0.001
Diabetes 6335(8.4) 5377(12.1) < 0.001
Heart disease 6431(8.5) 8845(19.8) < 0.001
Chronic kidney disease 672(0.9) 738(1.7) < 0.001
Cancer 1903(2.5) 2055(4.6) < 0.001
Alcohol dependence syndrome 53(0.1) 677(1.5) < 0.001
Tobacco use 173(0.2) 283(0.6) < 0.001
Table 3.  Demographic data and comorbidity comparison of the study subjects.
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Table 4 reports the occurrences of RA over the 14-year follow-up period for the two cohorts. At the end 
of follow-up, there were 1,555 incident RA cases, including 718 from the depression cohorts and 837 from 
the non-depression cohorts. The incidence of RA was significantly higher in the depression cohorts than in 
non-depression cohorts (2.07 vs. 1.21 per 1,000 PYs). Multivariate Cox proportional hazard regression model 
revealed that the subjects with depression had 65% higher risk of developing RA compared with those without 
depression (95% CI, 1.41–1.77). In both male and female groups, the finding indicated that depression was signif-
icantly related to the subsequent risk of RA. The incidence of RA was comparable between men and women, with 
adjusted HRs of 1.61 (95%CI, 1.28–2.02) and 1.55 (95% CI, 1.34–1.74), respectively (P = 0.91). The effects of age 
was statistically significant in both sexes, and the increased RA risk subsequent to depression was observed for 
subjects aged 40 or less, with adjusted HRs of 1.95 (95% CI, 1.37–2.48) in females and 2.04 (95% CI, 1.09–3.86) 
in males. The interactions between age and depression on RA were confirmed by further analyses showing that 
the interaction term was statistically significant in both sexes (P < 0.01 in both). As to the risk in relation to time 
since depression onset, the higher incidence rate of RA in the depression cohorts, as compared to non-depression 
cohorts, was observed in the 3–5 and > 5 year periods after onset of depression, with adjusted HRs of 1.83 
(95% CI, 1.61–2.19) and 1.58 (95% CI, 1.34–1.79), respectively.
Discussion
To the best of our knowledge, this is the first evidence-based cohort study applying a large nationwide 
claims-based data to address the bidirectional relationships between RA and depression, allowing for more potent 
validation of findings concerning the temporal association between these two diseases.
This 14-year follow-up study suggests that RA cohorts have nearly 70% higher risk of depression than non-RA 
cohorts. This finding is consistent with earlier research and adds to the growing body of literatures on this topic3–5,13,14. 
Furthermore, based on the stratified analysis for risk of depression subsequent to RA, we discovered that younger 
RA subjects, regardless of gender (aged 40 years or younger), carried the highest adjusted HRs for the risk of 
depression compared to non-RA controls of similar age, thus concurring with prior results14. A possible explana-
tion for this finding is that most young RA subjects may be actively employed, and RA typically progresses and 
ultimately results in chronic functional disability. Therefore, this joint impact of physical limitations and work 
restrictions may negatively affect the individual and trigger negative affectivity, as indicated by higher level of 
depression17. In addition, we observed that a higher risk of depression occurred within 2 years after RA diagnosis. 
It was inferred that the newly-diagnosed patients might be psychologically fragile and overwhelmed by RA symp-
toms18. Therefore, future studies could assess the benefit of implementing a standardized care pathway, which 
closely evaluates psychological status among RA patients within the first years of diagnosis2,3,19.
Regarding the risk of RA onset subsequent to depression, our findings showed that subjects with depression 
are at an elevated risk of developing RA, echoing previous reports15,16. Furthermore, a sensitivity analysis, limited 
to the cases that were admitted to the hospitals due to the primary diagnosis of depression, also indicated that 
RA risk was slightly greater for inpatients with depression, with adjusted HRs of 1.75 (95% CI, 1.58–1.93). All of 
these results further supported the premise that the elevated level of proinflammatory cytokines emerging from 
psychological disorders may provoke chronic medical illnesses, such as RA, through protracted immune dysreg-
ulation20,21. The findings, however, are inconsistent with a former report14. This disparity can be explained by the 
difference in screening measures and design used in both studies. van’t Land and colleagues used a self-reported 
questionnaire to arrive at a psychiatric diagnosis of depression14, a procedure which may have obscured the 
Variables
Non-depression cohort Depression cohort HR (95% CI)
Case PYs Incidence Case PYs Incidence Crude Adjusted
All 837 692396.22 1.21 718 347046.11 2.07 1.71 (1.55–1.89) 1.65* (1.41–1.77)
Sex
 Female 664 416464.90 1.59 560 209084.69 2.68 1.68 (1.50–1.88) 1.55ξ (1.34–1.74)
 < = 40 90 144727.65 0.62 98 72211.49 1.36 2.18 (1.64–2.91) 1.95Υ (1.37–2.48)
 41–60 317 169788.73 1.87 299 84961.55 3.51 1.89 (1.61–2.21) 1.62Υ (1.38–1.93)
 60+ 257 101948.51 2.52 163 51911.65 3.14 1.24 (1.02–1.51) 1.19Υ (0.98–1.47)
 Male 173 275931.32 0.63 158 137961.42 1.15 1.83 (1.47–2.26) 1.61ξ (1.28–2.02)
 < = 40 20 94640.07 0.21 25 47264.23 0.52 2.50 (1.39–4.51) 2.04Υ (1.09–3.86)
 41–60 71 101874.80 0.70 67 50937.94 1.32 1.89 (1.35–2.64) 1.61Υ (1.13–2.28)
 60+ 82 79416.45 1.03 66 39759.25 1.66 1.60 (1.16–2.21) 1.40Υ (0.99–1.96)
Follow-up (years)
 ≦ 2 245 9526.52 25.72 204 4892.39 41.69 1.62 (1.35–1.96) 1.47* (1.14–1.76)
 3–5 156 49293.82 3.16 153 25200.05 6.07 1.94 (1.54–2.40) 1.83* (1.61–2.19)
 > 5 436 633575.88 0.68 361 316953.66 1.14 1.66 (1.44–1.91) 1.58* (1.34–1.79)
Table 4.  Association of RA with depression stratified by sex, age, and follow-up years. Incidence rate is per 
1,000 PYs. Υ Model adjusted for urbanization level, monthly income, and comorbidity ξ Model adjusted for 
age, urbanization level, monthly income, and comorbidity. *Model adjusted for age, gender, urbanization level, 
monthly income, and comorbidity.
www.nature.com/scientificreports/
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findings due to recall and social desirability biases. Also, the cross-sectional design employed in that study does 
not allow for any inference about any cause-and-effect relationships between the tested variables.
With the exception of elderly subjects, our findings indicated that the total, and age- and sex- specific inci-
dence rates of RA were consistently and significantly higher in the depression cohorts than in non-depression 
cohorts. We also observed that the risk of RA among depression patients was higher among subjects aged 40 
years or younger. Two potential reasons may account for this finding. First, once subjects with a proinflammatory 
disposition have been diagnosed with depression, at younger age, they would be, subsequently, be at a higher risk 
of having RA, as compared to individuals who are older. Second, adults aged 40 years or younger are typically 
actively engaged in the labor market22, and accordingly, the combined stress of the workload and the need to cope 
with the clinical manifestations of depression, may insidiously aggravate the level of plasma concentrations of 
inflammatory cytokines, such as tumor necrosis factor-α (TNF-α ), interleukin-1 (IL-1) or IL-6, thus increasing 
the vulnerability to RA19,23.
Although the current study provided support for an empirical link between RA and depression, the exact 
pathophysiological mechanisms involved in these two illnesses still remains elusive1. Neurotransmitter deregula-
tion and dysfunctional intracellular signaling, however, was suggested as a link between psychological stress and 
immune-related disease. For example, exposure to a chronic negative mood has been related to dysfunction of the 
hypothalamic-pituitary-adrenal (HPA) axis and the peripheral release of glucocorticoids, along with increased 
activation of the sympathetic, as well as decreased activation of the parasympathetic branches of the autonomic 
nervous system, thereby inducing the expression of inflammatory markers, which in turn produce initiation 
and progression of autoimmune diseases8,9. Conversely, a growing body of evidence has also indicated that these 
proinflammatory cytokines, such as TNF-α and some interleukins, may mediate the HPA activation in response 
to various threats to homeostatic balance, and could, therefore, play a decisive role in the generation of major 
depression24,25.
Additionally, evidence has also supported the link between RA and depression through the activation of intra-
cellular signaling pathway, such as SAPK/MAPK and PI-3K/AKT/mTOR. The SAPK/MAPK pathway was found 
to be related to the synovial hyperplasia and MMP gene expression, which may further degrade the collagen 
matrix components of the joints, thereby inducing a greater susceptibility of RA10,26. Both animal experiments 
and human studies have reported that MAPK had been increasingly recognized as an important regulator of the 
central nervous system (CNS), and was implicated in neuronal axonal development, inflammation and depres-
sion27,28. As to the influence of the PI-3K/AKT/mTOR pathway, it has been established that it not only causes the 
aggressiveness of immune cell and synoviocyte proliferation to provoke development of RA10, but also plays a 
crucial role in the function of dopamine, a neurotransmitter whose malfunctioning has been associated with a 
greater risk for reduced neuroprotection and the development of psychosis12.
Several important limitations of this study should be noted when interpreting the results. First, we could not 
account for several potential confounding factors, such as social networks, religious beliefs, or educational level 
because such data were unavailable in the LHID. Future research using those untested variables is needed to 
better assess if the present findings could be replicated across diverse groups of individuals. Second, the identi-
fication of exposure and outcome were based on ICD-9-CM, and misclassification is possible. To minimize this 
error, we selected the subjects with either RA or depression only after they were recorded as having either at least 
three outpatient visits reporting consistent diagnoses or one inpatient admission. It should also be noted that the 
NHI of Taiwan randomly samples claims from hospitals, interviews patients, and reviews medical charts to verify 
the accuracy of medical records29. Third, as data regarding RA severity were unavailable in this database, failure 
to adjust for the level of disability might lead to the bias. Nonetheless, the multivariate analysis applied in this 
study further considered the impact of several comorbidities with physical impairments, including hypertension, 
stroke, diabetes mellitus, heart disease, chronic kidney disease, tobacco use, alcohol dependence syndrome, and 
cancer. Furthermore, we performed a sensitivity analysis that was limited to only those RA subjects without 
comorbidities to test the robustness of our findings. The findings of this analysis revealed that RA subjects with 
no known comorbidities still had a higher risk of depression when compared to the general population, with 
adjusted HRs of 1.73 (95% CI, 1.55–1.93). Fourth, a surveillance bias may also have occurred, as those patients 
with either RA or depression may have been overrepresented in health-care encounters, as compared to those in 
the control group. To address that issue, we calculated the frequency of ambulatory care visits within the period 
from index date to the end of the follow-up period for each subject and further adjusted it in the multivariate 
regression model. The results of the reanalysis revealed that the overall adjusted HRs of depression and RA were 
slightly lower, but still statistically significant, with 1.63 (95% CI, 1.46–1.90) and 1.59 (95% CI, 1.33–1.72), respec-
tively, suggesting that the number of ambulatory care visits did not appreciably impact the relationships reported 
earlier. Fifth, evidence derived from any observational cohort study is generally less robust than that obtained 
from randomized trials since cohort study designs are subject to various biases related to confounding effects. 
Despite our careful efforts to maintain adequate control of confounding factors, unpredictable biases could still 
remain if they stem from unmeasured or unknown confounders. Notwithstanding these limitations, the strengths 
of this study must also be acknowledged and included the immediate availability of data, the comprehensiveness 
of the database, and the statistical power derived from the samples’ large sizes. In addition, this retrospective 
14-year cohort study allowed us to examine in detail the bidirectional relation between RA and depression that 
may have long latency period, and the corresponding findings could serve as a reference for future basic studies.
In conclusion, this study examined the bidirectional nature of the associations between RA and depres-
sion. Our findings suggest that RA increases the risk of subsequent depression, and the onset of depression also 
increases the risk of developing RA. Given the serious burdens of these two diseases on the healthcare system, 
recognition of the bidirectional nature of the relationships between the two diseases, along with the detection of 
high-risk individuals could be beneficial for healthcare providers in guiding more effective treatment strategies to 
improve patient care and quality of life.
www.nature.com/scientificreports/
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Methods
Data Source. In order to remove financial barriers to medical care for all residents, the Taiwan Ministry of 
Health and Welfare launched a single-payer NHI program in 1995. At the end of 2011, > 99% of Taiwan’s popula-
tion was enrolled in this program18. Data used in this study were derived from the Longitudinal Health Insurance 
Database (LHID), which is a sub-data set of the National Health Insurance Research Database (NHIRD) and con-
tains longitudinal claims data from a randomly selected samples of one million NHI beneficiaries, representing 
5% of all enrollees in Taiwan. Because a multistage stratified systematic sampling method was applied, there were 
no statistically significant differences in sex or age between the sample group and all enrollees29. All data files were 
linked using scrambled identifications. This study was approved by the local institutional review board and ethics 
committee of Buddhist Dalin Tzu Chi Hospital, Taiwan (No. B10004021-1).
Study Population. Diagnoses in the insurance claims data were coded with International Classification of 
Disease, 9th Revision, Clinical Modification (ICD-9-CM). In this study, two cohort analyses were conducted to 
investigate the bidirectional associations between RA and depression. In the first analysis, we identified adult 
RA patients 20–80 years of age from medical claims with a diagnosis of 714.0, and those without RA diagnosis 
as a control group. In the second analysis, we selected individuals 20–80 years of age with a depression diagnosis 
(ICD-9-CM codes of 296.2, 296.3, 300.4 or 311) and a control group without a diagnosis of depression. The sub-
jects included in the case cohort were identified if they had at least three diagnoses in the ambulatory service or if 
they were admitted to the hospital with a primary diagnosis of RA (first analysis) or depression (second analysis) 
between 1998 and 2011. The index year was defined as the year of the first diagnosis of corresponding disease. For 
each case with RA (first analysis) or depression (second analysis), two control subjects were selected that were 
matched to the corresponding case for sex, age, and index year. In the first analysis, subjects were excluded if they 
had been diagnosed with depression before the first visit RA diagnosis to ascertain the temporal relationship 
between RA and the following onset of depression. In accordance with the same rationale, subjects with a diagno-
sis of RA before depression onset were excluded in the second analysis.
All subjects were then followed to the end of 2012 to obtain data on the incidence of corresponding disease 
within each of the two analyses. Follow-up person-years (PYs) were determined by calculating the time interval 
from the entry date to the earliest of one of the following: the first incidence of depression (first analysis) or RA 
(second analysis), the date of withdrawal from the insurance program or the date of December 31, 2012, which-
ever came first.
Demographic Variables and Comorbidities. The demographic variables used in this study included age, 
gender, income for estimating insurance payment, and urbanization level of the subject’s residential area. Monthly 
incomes were divided into three levels: ≤ New Taiwan Dollar (NTD) 17,880, NTD 17,881–NTD $43,900, and 
≥ NTD 43,901. Urbanization levels were divided into three strata: urban (levels 1–2), suburban (levels 3–4), and 
rural (levels 5–7) based on population density. Level 1 refers to the “most urbanized” and level 7 refers to the 
“least urbanized” communities30. Baseline comorbidities for each subjects included hypertension (ICD-9-CM 
401–405), stroke (ICD-9-CM 430–438), diabetes (ICD-9-CM 250), heart disease (ICD-9-CM 410–429), chronic 
kidney disease (ICD-9-CM 585), tobacco use (ICD-9-CM 305.1), alcohol dependence syndrome (ICD-9-CM 
303), and cancer (ICD-9-CM 140–208).
Statistical Analysis. Intergroup difference was evaluated using the independent-samples t-test for continu-
ous variables and the chi-square test or Fisher exact test for categorical variables. In the first analysis, we assessed 
the overall and sex-specific incidence of depression for RA cohorts and for non-RA cohorts. To assess the risk of 
developing depression associated with RA, Cox proportional hazard regression model was used to estimate the 
crude and adjusted hazard ratios (HRs) of developing depression among subjects with RA compared with the 
control group. Analytic procedure in the second analysis was identical to that applied in the first analysis. We used 
Cox proportional hazard regression model to assess the crude and adjusted HRs for the risk of RA in relation to 
depression. Furthermore, the analyses stratified by age, gender and follow-up time were conducted using Cox 
proportional hazards regression model to assess the bidirectional associations between these two diseases. The 
assumption of proportional hazards was confirmed by plotting a survival function versus a survival time graph 
of the log, log (survival), versus that of log survival time. All analyses were conducted using SAS version 9.3 (SAS 
Institute Inc., Cary, NC, USA), and at a p < 0.05 statistically significant level.
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